Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00518570
Status:
COMPLETED
Last Update Posted:
2007-08-20
First Post:
2007-08-16
Brief Title:
Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder PMDD
Sponsor:
Berkshire Health Systems
Organization:
Berkshire Health Systems
Study Overview
Official Title:
A Pilot Study Levetiracetam in the Treatment of Patients With Premenstrual Dysphoric Disorder
Status:
COMPLETED
Status Verified Date:
2007-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
pmdd
Brief Summary:
The purpose of this study is to investigate the clinical efficacy of Levetiracetam in the treatment of symptoms of premenstrual dysphoric disorder PMDD in an open label study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| BMC03-010 | None | None | None |